Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Techniques (Electroencephalography (EEG), Brain-computer interface (BCI),

The noninvasive traumatic brain injury diagnostic equipment market is projected to reach US$ 3.91 billion by 2031 from US$ 1.70 billion in 2024. The market is estimated to register a CAGR of 12.7% during 2025-2031. Major factors driving the market growth include a surging number of traumatic brain injuries, a shift toward noninvasive technologies, technological advancements, and AI integration are propelling the adoption of noninvasive traumatic brain injury diagnostic equipment. Further, expansion into ambulatory and point-of-care settings will likely boost the market during the forecast period. However, high equipment cost and maintenance, scarcity of trained personnel and limited awareness, regulatory, standardization and validation challenges are among the market deterrents.

As imaging hardware becomes more precise and data-rich, there is a growing demand for tools that analyze data, reduce human error, shorten diagnosis time, and push diagnostics closer to real‑time. AI integration improves imaging speed, resolution, and diagnostic accuracy. Philips and SyntheticMR AB's Smart Quant Neuro 3D system, launched in March 2024, uses AI-powered SmartSpeed reconstruction to acquire images up to three times faster than traditional methods, with up to 65% higher resolution. This enhancement improves image clarity and reduces scan time, which is critical for trauma cases. Beyond imaging, AI is expanding the capabilities of non-imaging diagnostic technologies. Wearable and point-of-care devices are becoming increasingly advanced, enabling continuous monitoring through wearable EEGs, AI-assisted detection of intracranial bleeding in CT scans, and predictive modeling of TBI outcomes. The network achieved high accuracy in detecting and classifying different types of intracranial bleeding, such as epidural, subdural, and subarachnoid hemorrhages. This factor is central to the market's rapid growth, especially in noninvasive diagnostic modalities.

The comparative company analysis evaluates and categorizes the Noninvasive Traumatic Brain Injury Diagnostic Equipment market based on product portfolio (product satisfaction, product features, and availability), recent market developments (merger & acquisition, new product launch & enhancement, investment & funding, award, agreement, collaboration, & partnership, recognition, and expansion), and geographic presence that aids better decision-making and understanding of the competitive landscape. The report profoundly explores the recent significant developments and innovations by the leading vendors in the global Noninvasive Traumatic Brain Injury Diagnostic Equipment market. The key market players are GE Healthcare Technologies Inc., Elekta AB, Siemens Healthineers, Koninklijke Philips N.V., Medtronic, Natus Medical, Inc., Integra LifeSciences Holdings Corp, and BrainScope Company, Inc.

In terms of techniques, the Noninvasive Traumatic Brain Injury Diagnostic Equipment market is bifurcated into electroencephalography (EEG), brain-computer interface (BCI), eye tracking and near-infrared spectroscopy (NIRS), magnetic resonance imaging (MRI), magnetoencephalography (MEG), transcranial magnetic stimulation (TMS), cerebral metabolic rate of oxygen (CMRO2), intracranial pressure, and others. The magnetic resonance imaging (MRI) segment accounted for the largest share of the noninvasive traumatic brain injury diagnostic equipment market in 2024. Due to advancements in MRI, it has become a structural imaging tool into a functional and metabolic diagnostic powerhouse for TBI.

Based on noninvasive ICP, the noninvasive traumatic brain injury diagnostic equipment market is categorized into transcranial doppler ultrasonography (TCD), tympanic membrane displacement (TMD), optic nerve sheath diameter (ONSD), magnetic resonance imaging (MRI), and computer tomography (CT), and fundoscopy and papilledema. The magnetic resonance imaging (MRI), and computer tomography (CT) segment accounted for the largest share of the noninvasive traumatic brain injury diagnostic equipment market in 2024. Magnetic Resonance Imaging (MRI) and computed tomography (CT) are the foundational pillars of the noninvasive traumatic brain injury (TBI) diagnostic equipment market. CT is the first-line imaging modality in acute TBI due to its speed, wide availability, and ability to identify life-threatening injuries like intracranial hemorrhages and skull fractures rapidly. MRI can detect subtle brain injuries, particularly diffuse axonal injury (DAI), that are often missed on CT. AI-powered algorithms are being developed to automatically detect and quantify hematomas, midline shifts, and other signs of elevated intracranial pressure, reducing the time for diagnosis and improving a clinician's ability.

By device, the noninvasive traumatic brain injury diagnostic equipment market is bifurcated into imaging devices and monitoring devices. The imaging devices segment held a larger market share in 2024, owing to the high utilization of the imaging devices in the diagnosis of TBI.

Based on end users, the noninvasive traumatic brain injury diagnostic equipment market is categorized into hospitals and clinics, diagnostic centers, and others. The hospitals and clinics segment held a larger share of the market in 2024. Hospitals and clinics are preferred end‑users for several reasons: they typically have more comprehensive infrastructure, skilled staff, and the financial capacity to procure and maintain advanced diagnostic tools.

Companies operating in the noninvasive traumatic brain injury diagnostic equipment market adopt various organic and inorganic strategies. The organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaborations, and partnerships. These growth strategies allow the market players to expand their businesses, enhance their geographic presence, and contribute to the overall market growth. Furthermore, acquisitions and partnerships helped strengthen their customer base and extend their product portfolios. A few significant developments by key Noninvasive Traumatic Brain Injury Diagnostic Equipment market players are listed below.

In January 2025, Medtronic achieved CE Mark approval for BrainSense Adaptive deep brain stimulation and Electrode Identifier. This European approval introduces the world's only closed-loop DBS system with real-time, self-adjusting brain stimulation for Parkinson's patients.

In January 2025, Philips launched the AI-enabled CT 5300 at the 23rd Asian Oceanian Congress of Radiology (AOCR) 2025. Philips also celebrated the installation of 1500+ Helium Free 1.5T wide Bore (70 cm) MRI systems worldwide.

In March 2024, Siemens Healthineers announced the Food and Drug Administration clearance of the MAGNETOM Terra.X, a second-generation clinical 7-tesla magnetic resonance imaging scanner that dramatically advances the capabilities of 7T MR scanning with new hardware and XA60A software.

Reasons to Buy


Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Noninvasive Traumatic Brain Injury Diagnostic Equipment market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the global Noninvasive Traumatic Brain Injury Diagnostic Equipment market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution Show more